Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 497

    1.

    Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial.

    Rooney JF, Straus SE, Mannix ML, Wohlenberg CR, Alling DW, Dumois JA, Notkins AL.

    Ann Intern Med. 1993 Feb 15;118(4):268-72.PMID: 8380540 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.

    Spruance SL, Rea TL, Thoming C, Tucker R, Saltzman R, Boon R.

    JAMA. 1997 May 7;277(17):1374-9.PMID: 9134943 [PubMed - indexed for MEDLINE]Related articles

    3.

    Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies.

    Baker D, Eisen D.

    Cutis. 2003 Mar;71(3):239-42.PMID: 12661753 [PubMed - indexed for MEDLINE]Related articles

    4.

    Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes.

    Mattison HR, Reichman RC, Benedetti J, Bolgiano D, Davis LG, Bailey-Farchione A, Remington M, Winter C, Corey L.

    Am J Med. 1988 Aug 29;85(2A):20-5.PMID: 3044086 [PubMed - indexed for MEDLINE]Related articles

    5.

    Treatment of recurrent herpes simplex labialis with oral acyclovir.

    Spruance SL, Stewart JC, Rowe NH, McKeough MB, Wenerstrom G, Freeman DJ.

    J Infect Dis. 1990 Feb;161(2):185-90.PMID: 2153735 [PubMed - indexed for MEDLINE]Related articles

    6.

    A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection.

    Douglas JM, Critchlow C, Benedetti J, Mertz GJ, Connor JD, Hintz MA, Fahnlander A, Remington M, Winter C, Corey L.

    N Engl J Med. 1984 Jun 14;310(24):1551-6.PMID: 6328298 [PubMed - indexed for MEDLINE]Related articles

    8.

    Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial.

    Peacock JE Jr, Kaplowitz LG, Sparling PF, Durack DT, Gnann JW Jr, Whitley RJ, Lovett M, Bryson YJ, Klein RJ, Friedman-Kien AE, et al.

    Am J Med. 1988 Sep;85(3):301-6.PMID: 3046350 [PubMed - indexed for MEDLINE]Related articles

    9.

    Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir.

    Straus SE, Takiff HE, Seidlin M, Bachrach S, Lininger L, DiGiovanna JJ, Western KA, Smith HA, Lehrman SN, Creagh-Kirk T, et al.

    N Engl J Med. 1984 Jun 14;310(24):1545-50.PMID: 6328297 [PubMed - indexed for MEDLINE]Related articles

    10.

    Herpes labialis treatment with acyclovir 5 per cent ointment.

    Raborn GW, McGaw WT, Grace M, Houle L.

    J Can Dent Assoc. 1989 Feb;55(2):135-7.PMID: 2645030 [PubMed - indexed for MEDLINE]Related articles

    11.

    The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures.

    Miller CS, Cunningham LL, Lindroth JE, Avdiushko SA.

    J Am Dent Assoc. 2004 Sep;135(9):1311-8.PMID: 15493396 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis.

    Evans TG, Bernstein DI, Raborn GW, Harmenberg J, Kowalski J, Spruance SL.

    Antimicrob Agents Chemother. 2002 Jun;46(6):1870-4.PMID: 12019102 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Acyclovir vs isoprinosine (immunovir) for suppression of recurrent genital herpes simplex infection.

    Kinghorn GR, Woolley PD, Thin RN, De Maubeuge J, Foidart JM, Engst R.

    Genitourin Med. 1992 Oct;68(5):312-6.PMID: 1385295 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialis.

    Kaminester LH, Pariser RJ, Pariser DM, Weiss JS, Shavin JS, Landsman L, Haines HG, Osborne DW.

    J Am Acad Dermatol. 1999 Dec;41(6):996-1001.PMID: 10570387 [PubMed - indexed for MEDLINE]Related articles

    15.

    Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.

    Mertz GJ, Loveless MO, Levin MJ, Kraus SJ, Fowler SL, Goade D, Tyring SK.

    Arch Intern Med. 1997 Feb 10;157(3):343-9.PMID: 9040303 [PubMed - indexed for MEDLINE]Related articles

    16.

    Oral acyclovir in prevention of herpes labialis. A randomized, double-blind, multi-centered clinical trial.

    Raborn GW, Martel AY, Grace MG, McGaw WT.

    Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Jan;85(1):55-9.PMID: 9474615 [PubMed - indexed for MEDLINE]Related articles

    17.

    Failure of acyclovir cream in treatment of recurrent herpes labialis.

    Shaw M, King M, Best JM, Banatvala JE, Gibson JR, Klaber MR.

    Br Med J (Clin Res Ed). 1985 Jul 6;291(6487):7-9.PMID: 3926067 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Topical acyclovir in the management of recurrent herpes labialis.

    Fiddian AP, Ivanyi L.

    Br J Dermatol. 1983 Sep;109(3):321-6.PMID: 6351894 [PubMed - indexed for MEDLINE]Related articles

    19.

    Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study.

    Raborn GW, McGaw WT, Grace M, Tyrrell LD, Samuels SM.

    J Am Dent Assoc. 1987 Jul;115(1):38-42.PMID: 3301980 [PubMed - indexed for MEDLINE]Related articles

    20.

    Successful treatment of herpes labialis with topical acyclovir.

    Fiddian AP, Yeo JM, Stubbings R, Dean D.

    Br Med J (Clin Res Ed). 1983 May 28;286(6379):1699-701.PMID: 6405939 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data